Akebia Therapeutics, Inc.’s AKBA share price has dipped by 22.21%, which has investors questioning if this is right time to ...

ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announces its participation in the 2025 NeauxCancer Conference organized by the Cancer Advocacy ...